![](/img/cover-not-exists.png)
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10
Lamarthée, B, Malard, F, Gamonet, C, Bossard, C, Couturier, M, Renauld, J-C, Mohty, M, Saas, P, Gaugler, BLanguage:
english
Journal:
Mucosal Immunology
DOI:
10.1038/mi.2015.61
Date:
July, 2015
File:
PDF, 1.47 MB
english, 2015